Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference62 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;J Ferlay;Int J Cancer,2015
2. Canadian Cancer Statistics 2013,2013
3. Hepatocellular carcinoma;A Forner;Lancet,2012
4. Hepatocellular carcinoma;HB El-Serag;N Engl J Med,2011
5. Management of hepatocellular carcinoma: An update;J Bruix;Hepatology,2011
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma;Aging;2023-04-08
2. Advanced hepatocellular carcinoma and palliative care: a scoping review;BMJ Supportive & Palliative Care;2022-11-17
3. Response assessment methods for patients with hepatic metastasis from rare tumor primaries undergoing transarterial chemoembolization;Clinical Imaging;2022-09
4. Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma;Contrast Media & Molecular Imaging;2022-06-08
5. Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma;Canadian Liver Journal;2022-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3